BIOTREND offers a variety of fluorescent reagents and related biochemicals that find applications in life science research and drug discovery including High Throughput Drug Screening (HTS).with more than 350 lipids, sphingosines, inositides and products for Signal Transduction research in pharmacology and neurochemistry research. Our kits are simple and convenient to use, and are superior in performance. Researchers need little to no time for assay optimization. We are specialized in biochemical and cell-based assays for both routine laboratory tests and high-throughput drug screening applications. We focus on harmless non-radioactive assay formats such as fluorescence, bio- and chemiluminescence detection techniques.
Pharma Medica Research Inc. provides Clinical Trials Research (Phases I-IV), Bioanalytical, Regulatory, Data Management and Statistical Services to Innovative and Generic Pharmaceutical and Biotechnology companies worldwide. At the forefront of the North American CRO industry, our reputation is built upon: High Quality service on time…..every time! Innovation and Responsiveness Integrity and Reliability Regulatory Compliant without Compromise Pharma Medica Research Inc. is dedicated to building long term relationships with its clients by providing quality data at a competitive price through its exceptionally capable and dedicated team of scientific and business professionals.
Founded in 1987, Spectrum Pharmaceutical Research Corp. is a contract research organization (CRO) that provides pharmaceutical, biotechnology and medical device companies with cost-effective expertise in the drug development process. Our goal is to provide the highest level of customer service in the CRO industry, cost-effectively producing quality results that meet or exceed our clients' expectations of performance.
Orthometrix, Inc. markets, sells and services several musculoskeletal product lines used in pharmaceutical research, diagnosis and monitoring of bone and muscle disorders, sports medicine, rehabilitative medicine, physical therapy and pain management. The Company offers five product lines. Its principal products are the pQCT (or XCT) series for research applications, the peripheral Quantitative Computed Tomography (pQCT) (or XCT) series for clinical applications, the Leonardo, the VibraFlex series and the Orbasone. The Company markets, sells and services its products primarily in the United States and Canada. It markets, sells and services its products and devices through two divisions: Healthcare Division and Sports & Fitness Division. On February 18, 2007, Kathy Smith Lifestyles (KSL) entered into a sales agreement with the Company. KSL agreed to promote the VibraFlex Home Edition. (Source: 10-K)
NAEJA was established in 1999 with a rollover of assets, including staff, equipment and intellectual property, from SynPhar Laboratories Inc. and research contracts from DrisCorp Inc. What began as a full fledged pharmaceutical company with an extensive intellectual property portfolio and a proven track record has evolved into an internationally respected pharmaceutical outsource service provider. NAEJA has carved a unique niche in the outsource industry offering extensive discovery experience and expertise. The flexibility NAEJA offers to custom design drug discovery services has kept NAEJA at the forefront of the industry. NAEJA's commitment to global health, extensive drug discovery experience and attention to continual improvement are key factors that contribute to NAEJA's success and keep the company at the forefront of the industry. NAEJA will continue to focus on delivering optimum service in a continued commitment to the pharmaceutical industry. It is through international teamwork that we must wage our war against illness and NAEJA will continue on with its mission making significant contributions as a valuable team member.
HFL regularly provides expert advice and consultancy services for our clients across sports, pharmaceutical and healthcare sectors. Depending on the nature of the advice, we often offer this as part of our bid for new programmes of work. Our particular areas of expertise include: Feasibility assessment Recommendations on methodologies Pharmaco- and toxicokinetics Analytical development strategy Optimising laboratory services within new product development activities Link to Quotient Bioresearch
CML Healthcare Income Fund (the Fund) is an open-ended trust that owns CML Healthcare Inc. (CML), which is engaged in healthcare diagnostic services business in Canada. CML is a community-based provider of laboratory testing services in Ontario and a provider of medical imaging services in Canada. The Company’s laboratory testing services conduct medical tests for physicians to assist in patient diagnosis and treatment. Its medical imaging services operates 115 community-based medical imaging facilities in five provinces across Canada, including one clinic in Quebec, two in Manitoba, eight in Alberta, 14 in British Columbia and 90 in Ontario. In July 2007, the Fund closed the acquisition of Brantford Medical Imaging and ProMed Echo-Ultrasound. On February 29, 2008, the Fund acquired American Radiology Services, Inc (ARS), through the acquisition of its holding company ARS Holding, Inc (ARS Holding). (Source: ARS)
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory